Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Cost-effectiveness analysis of baricitinib versus dupilumab for moderate to severe atopic dermatitis: an Italian healthcare system perspective
PaperCitations, authors & open-access status
Cost-effectiveness analysis of baricitinib versus dupilumab for moderate to severe atopic dermatitis: an Italian healthcare system perspective is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 3 citations, 2023 year and diamond oa status.
3
Citations
2023
Year
diamond
OA Status